Capital World Investors Ab Cellera Biologics Inc. Transaction History
Capital World Investors
- $659 Billion
- Q2 2025
A detailed history of Capital World Investors transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Capital World Investors holds 13,361,096 shares of ABCL stock, worth $57.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,361,096
Previous 13,361,096
-0.0%
Holding current value
$57.1 Million
Previous $29.8 Million
53.81%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ABCL
# of Institutions
148Shares Held
114MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$118 Million0.96% of portfolio
-
Baillie Gifford & CO10.4MShares$44.2 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$36.2 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$19.4 Million0.02% of portfolio
-
Two Sigma Investments, LP New York, NY4.11MShares$17.6 Million0.03% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.22B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...